Answer:
Parenchyma, Collenchyma, Sclerenchyma, Vascular tissues
Explanation:
Answer:
i think but not really sure the answer is
an organism, especially a soil bacterium, fungus, or invertebrate, that decomposes organic material.
hope this helps !!!
Answer:
Phase III
Explanation:
The given condition fall in the trial phase (Phase III) of cinical study which aims to:
- Determine drug's effectiveness (primary goal)
- Determine long-term drug safety
- Confirm findings
In Phase III, randomised, double-blind, placebo-controlled, parallel group study is majorly to evaluate the efficacy and safety of placebo in episodic migraine prevention in children (6 to < 12 years of age) and adolescents (12 to < 18 years of age).
The trial consists of four phases: screening; double-blind therapy period for 24 weeks in which placebo or Erenumab is given to subject as dose 1, dose 2 or dose 3 (based on the participant's body weight) once a month via subcutaneous injection; optional dose level blinded extension phase (40 weeks) which involves subjects recieve dose1, 2 and 3 of placebo, and at last it follows a safety follow-up phase for 12 weeks (after 16 weeks of the last dose of investigational drug).
Hence, the clinical phase is phase III.
Answer: SECONDARY CELL WALL.
Explanation: When cell wall grow,it becomes thickened,then it further deposits new layers of a different material (different from that of the primary cell wall) from where secondary cell wall is formed.
This secondary cell wall is made up of cellulose,hemicellulose,and lignin.
They function in providing additional strength,support, rigidity to cells and the larger plant.
